{
    "2021-06-26": [
        [
            {
                "time": "2021-06-15",
                "original_text": "Here's Why Novavax's Solid Vaccine Data Didn't Move the Stock",
                "features": {
                    "keywords": [
                        "Novavax",
                        "vaccine",
                        "data",
                        "stock"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-06-15",
                "original_text": "Is Novavax's COVID-19 Vaccine Superior to the mRNA Vaccines?",
                "features": {
                    "keywords": [
                        "Novavax",
                        "COVID-19",
                        "vaccine",
                        "mRNA"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-11-18",
                "original_text": "Pfizer Developed a Vaccine in Less Than a Year. Thereâ€™s More to Come.",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "vaccine",
                        "year",
                        "development"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-25",
                "original_text": "UPDATE 1-U.S. FDA adds warning about rare heart inflammation to Pfizer, Moderna COVID vaccines",
                "features": {
                    "keywords": [
                        "FDA",
                        "warning",
                        "heart",
                        "inflammation",
                        "Pfizer",
                        "Moderna",
                        "vaccines"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}